An update on Candida dubliniensis;Actualités sur Candida dubliniensis

Medecine et Maladies Infectieuses

Volumn 38, Issue 1, 2008, Pages 1-7

  Paugam, A ^a   Baixench, M T ^a   Viguie C ^a  

^a Assistance publique Hôpitaux de Paris ^*  (France)

Author keywords

Candida albicans; Candida dubliniensis

Indexed keywords

FLUCONAZOLE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR BIOLOGY; MOUTH CAVITY; NEW SPECIES; NONHUMAN; REVIEW; THRUSH;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS, ORAL; GENOTYPE; HUMANS; VIRULENCE;

EID: 38749149583     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2007.10.008     Document Type: Review

References (78)

1. Sullivan D., Bennett D., Henman M., Harwood P., Flint S., Mulcahy F., et al. Oligonucleotide fingerprinting of isolates of Candida species other than C. albicans and of atypical Candida species from human immunodeficiency virus-positive and AIDS patients. J Clin Microbiol 31 8 (1993) 2124-2133
2. Sullivan D.J., Westerneng T.J., Haynes K.A., Bennett D.E., and Coleman D.C. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals. Microbiology 141 Pt 7 (1995) 1507-1521
3. Kirkpatrick W.R., Lopez-Ribot J.L., McAtee R.K., and Patterson T.F. Growth competition between Candida dubliniensis and Candida albicans under broth and biofilm growing conditions. J Clin Microbiol 38 2 (2000) 902-904
4. Gilfillan G.D., Sullivan D.J., Haynes K., Parkinson T., Coleman D.C., and Gow N.A. Candida dubliniensis: phylogeny and putative virulence factors. Microbiology 144 Pt 4 (1998) 829-838
5. Al Mosaid A., Sullivan D., Salkin I.F., Shanley D., and Coleman D.C. Differentiation of Candida dubliniensis from Candida albicans on staib agar and caffeic acid-ferric citrate agar. J Clin Microbiol 39 1 (2001) 323-327
6. Staib P., and Morschhauser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 42 9-10 (1999) 521-524
7. Al Mosaid A., Sullivan D.J., and Coleman D.C. Differentiation of Candida dubliniensis from Candida albicans on Pal's agar. J Clin Microbiol 41 10 (2003) 4787-4789
8. Khan Z.U., Ahmad S., Mokaddas E., and Chandy R. Tobacco agar, a new medium for differentiating Candida dubliniensis from Candida albicans. J Clin Microbiol 42 10 (2004) 4796-4798
9. Loreto E.S., Bolzan A.R., Linares C.E., Boff E., Santurio J.M., and Alves S.H. Evaluation of 5 new media containing extracts of seeds applied to Candida dubliniensis screening. Diagn Microbiol Infect Dis 55 3 (2006) 191-193
10. Faggi E., Pini G., Campisi E., Martinelli C., and Difonzo E. Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus infected and non-infected patients and in a yeast culture collection. Mycoses 48 3 (2005) 211-215
11. ® Candida medium with Pal's medium for rapid identification of Candida dubliniensis. J Clin Microbiol 43 11 (2005) 5768-5770
12. Eraso E., Sahand I.H., Villar-Vidal M., Marcos C., Dolores Moragues M., Madariaga L., et al. Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis. Med Mycol 44 7 (2006) 611-615
13. ® Fumouze to distinguish Candida dubliniensis from Candida albicans. Diagn Microbiol Infect Dis 55 2 (2006) 165-167
14. Marot-Leblond A., Beucher B., David S., Nail-Billaud S., and Robert R. Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies. J Clin Microbiol 44 1 (2006) 138-142
15. Mahnss B., Stehr F., Schafer W., and Neuber K. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis. Mycoses 48 1 (2005) 55-61
16. Cardenes-Perera C.D., Torres-Lana A., Alonso-Vargas R., Moragues-Tosantas M.D., Ponton-San Emeterio J., Quindos-Andres G., et al. Evaluation of API ID 32C and VITEK-2 to identify Candida dubliniensis. Diagn Microbiol Infect Dis 50 3 (2004) 219-221
17. Staib P., Moran G.P., Sullivan D.J., Coleman D.C., and Morschhauser J. Isogenic strain construction and gene targeting in Candida dubliniensis. J Bacteriol 183 9 (2001) 2859-2865
18. Joly S., Pujol C., and Soll D.R. Microevolutionary changes and chromosomal translocations are more frequent at RPS loci in Candida dubliniensis than in Candida albicans. Infect Genet Evol 2 1 (2002) 19-37
19. Sullivan D.J., Moran G.P., and Coleman D.C. Candida dubliniensis: 10 years on. FEMS Microbiol Lett 253 1 (2005) 9-17
20. McCullough M.J., Clemons K.V., and Stevens D.A. Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 37 2 (1999) 417-421
21. Coleman D., Sullivan D., Harrington B., Haynes K., Henman M., Shanley D., et al. Molecular and phenotypic analysis of Candida dubliniensis: a recently identified species linked with oral candidosis in HIV-infected and AIDS patients. Oral Dis 3 Suppl 1 (1997) S96-S101
22. Mirhendi H., Makimura K., Zomorodian K., Maeda N., Ohshima T., and Yamaguchi H. Differentiation of Candida albicans and Candida dubliniensis using a single-enzyme PCR-RFLP method. Jpn J Infect Dis 58 4 (2005) 235-237
23. Gee S.F., Joly S., Soll D.R., Meis J.F., Verweij P.E., Polacheck I., et al. Identification of four distinct genotypes of Candida dubliniensis and detection of microevolution in vitro and in vivo. J Clin Microbiol 40 2 (2002) 556-574
24. Moran G.P., Sullivan D.J., Henman M.C., McCreary C.E., Harrington B.J., Shanley D.B., et al. Antifungal drug susceptibilities of oral Candida dubliniensis isolates from human immunodeficiency virus (HIV)-infected and non-HIV-infected subjects and generation of stable fluconazole-resistant derivatives in vitro. Antimicrob Agents Chemother 41 3 (1997) 617-623
25. Akins R.A. An update on antifungal targets and mechanisms of resistance in Candida albicans. Med Mycol 43 4 (2005) 285-318
26. Pinjon E., Moran G.P., Coleman D.C., and Sullivan D.J. Azole susceptibility and resistance in Candida dubliniensis. Biochem Soc Trans 33 Pt 5 (2005) 1210-1214
27. Pinjon E., Jackson C.J., Kelly S.L., Sanglard D., Moran G., Coleman D.C., et al. Reduced azole susceptibility in genotype 3 Candida dubliniensis isolates associated with increased CdCDR1 and CdCDR2 expression. Antimicrob Agents Chemother 49 4 (2005) 1312-1318
28. Sullivan D., and Coleman D. Candida dubliniensis: characteristics and identification. J Clin Microbiol 36 2 (1998) 329-334
29. Coleman D.C., Sullivan D.J., Bennett D.E., Moran G.P., Barry H.J., and Shanley D.B. Candidiasis: the emergence of a novel species, Candida dubliniensis. AIDS 11 5 (1997) 557-567
30. Schmid J., Odds F.C., Wiselka M.J., Nicholson K.G., and Soll D.R. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol 30 4 (1992) 935-941
31. Schoofs A., Odds F.C., Colebunders R., Ieven M., and Goossens H. Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients. Eur J Clin Microbiol Infect Dis 16 4 (1997) 296-300
32. Martinez M., Lopez-Ribot J.L., Kirkpatrick W.R., Coco B.J., Bachmann S.P., and Patterson T.F. Replacement of Candida albicans with C. dubliniensis in human immunodeficiency virus-infected patients with oropharyngeal candidiasis treated with fluconazole. J Clin Microbiol 40 9 (2002) 3135-3139
33. Budtz-Jorgensen E. Histopathology, immunology, and serology of oral yeast infections. Diagnosis of oral candidosis. Acta Odontol Scand 48 1 (1990) 37-43
34. Sahin I., Oksuz S., Sencan I., Gulcan A., Karabay O., Gulcan E., et al. Prevalence and risk factors for yeast colonization in adult diabetic patients. Ethiop Med J 43 2 (2005) 103-109
35. Tekeli A., Dolapci I., Emral R., and Cesur S. Candida carriage and Candida dubliniensis in oropharyngeal samples of type-1 diabetes mellitus patients. Mycoses 47 7 (2004) 315-318
36. Bagg J., Sweeney M.P., Lewis M.A., Jackson M.S., Coleman D., Al M.A., et al. High prevalence of non-albicans yeasts and detection of anti-fungal resistance in the oral flora of patients with advanced cancer. Palliat Med 17 6 (2003) 477-481
37. Acikgoz Z.C., Sancak B., Gamberzade S., and Misirlioglu M. Prevalence of Candida dubliniensis among the stored vaginal Candida isolates in a Turkish hospital. Mycoses 47 9-10 (2004) 393-396
38. Al-Sweih N., Ahmad S., Khan Z.U., Khan S., and Chandy R. Prevalence of Candida dubliniensis among germ tube-positive Candida isolates in a maternity hospital in Kuwait. Mycoses 48 5 (2005) 347-351
39. Fotedar R., and Al Hedaithy S.S. Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients. Mycoses 47 3-4 (2004) 150-155
40. Peltroche-Llacsahuanga H., Dohmen H., and Haase G. Recovery of Candida dubliniensis from sputum of cystic fibrosis patients. Mycoses 45 1-2 (2002) 15-18
41. Tekeli A., Memikoglu O., Dolapci I., Koyuncu E., Yuksel O., and Tekeli E. The prevalence of Candida dubliniensis among germ tube positive Candida samples isolated from the respiratory tract. Saudi Med J 26 5 (2005) 885-887
42. Ahmad S., Khan Z., Mokaddas E., and Khan Z.U. Isolation and molecular identification of Candida dubliniensis from non-human immunodeficiency virus-infected patients in Kuwait. J Med Microbiol 53 Pt 7 (2004) 633-637
43. Pfaller M.A., and Diekema D.J. Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida. Clin Microbiol Infect 10 Suppl 1 (2004) 11-23
44. Tortorano A.M., Peman J., Bernhardt H., Klingspor L., Kibbler C.C., Faure O., et al. Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 23 4 (2004) 317-322
45. Meis J.F., Ruhnke M., De Pauw B.E., Odds F.C., Siegert W., and Verweij P.E. Candida dubliniensis candidemia in patients with chemotherapy-induced neutropenia and bone marrow transplantation. Emerg Infect Dis 5 1 (1999) 150-153
46. Brandt M.E., Harrison L.H., Pass M., Sofair A.N., Huie S., Li R.K., et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 6 1 (2000) 46-49
47. Pinjon E., Sullivan D., Salkin I., Shanley D., and Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 36 7 (1998) 2093-2095
48. Chan-Tack K.M. Fatal Candida dubliniensis septicemia in a patient with AIDS. Clin Infect Dis 40 8 (2005) 1209-1210
49. Carr M.J., Clarke S., O'Connell F., Sullivan D.J., Coleman D.C., and O'Connell B. First reported case of endocarditis caused by Candida dubliniensis. J Clin Microbiol 43 6 (2005) 3023-3026
50. Jabra-Rizk M.A., Falkler W.A., and Meiller T.F. Fungal biofilms and drug resistance. Emerg Infect Dis 10 1 (2004) 14-19
51. Ramage G., Vande Walle K., Wickes B.L., and Lopez-Ribot J.L. Biofilm formation by Candida dubliniensis. J Clin Microbiol 39 9 (2001) 3234-3240
52. Henriques M., Azeredo J., and Oliveira R. Candida albicans and Candida dubliniensis: comparison of biofilm formation in terms of biomass and activity. Br J Biomed Sci 63 1 (2006) 5-11
53. Kothavade R.J., and Panthaki M.H. Evaluation of phospholipase activity of Candida albicans and its correlation with pathogenicity in mice. J Med Microbiol 47 2 (1998) 99-102
54. De Bernardis F., Sullivan P.A., and Cassone A. Aspartyl proteinases of Candida albicans and their role in pathogenicity. Med Mycol 39 4 (2001) 303-313
55. Fotedar R., and Al-Hedaithy S.S. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis. Mycoses 48 1 (2005) 62-67
56. Vilela M.M., Kamei K., Sano A., Tanaka R., Uno J., Takahashi I., et al. Pathogenicity and virulence of Candida dubliniensis: comparison with C. albicans. Med Mycol 40 3 (2002) 249-257
57. Sullivan D., Haynes K., Bille J., Boerlin P., Rodero L., Lloyd S., et al. Widespread geographic distribution of oral Candida dubliniensis strains in human immunodeficiency virus-infected individuals. J Clin Microbiol 35 4 (1997) 960-964
58. Melkusova S., Lisalova M., Pavlik P., and Bujdakova H. The first clinical isolates of Candida dubliniensis in Slovakia. Mycopathologia 159 3 (2005) 369-371
59. Millon L., Piarroux R., Drobacheff C., Monod M., Bulle B., Bole J., et al. Candidose oropharyngée récidivante à Candida albicans et à Candida dubliniensis chez une patiente infectée par le VIH: aspects mycologiques, génotypiques et immunologiques. J Mycol Med 11 (2001) 153-158
60. Moalic V., Moalic E., Bellien V., Jezequel J., Garre M., Berthou C., et al. Première identification de Candida dubliniensis au centre hospitalier de Brest (France). Résultat d'une étude propective de 6 mois. J Mycol Med 11 (2001) 32-37
61. Binolfi A., Biasoli M.S., Luque A.G., Tosello M.E., and Magaro H.M. High prevalence of oral colonization by Candida dubliniensis in HIV-positive patients in Argentina. Med Mycol 43 5 (2005) 431-437
62. Milan E.P., de Laet Sant' Ana P., de Azevedo Melo A.S., Sullivan D.J., Coleman D.C., Lewi D., et al. Multicenter prospective surveillance of oral Candida dubliniensis among adult Brazilian human immunodeficiency virus-positive and AIDS patients. Diagn Microbiol Infect Dis 41 1-2 (2001) 29-35
63. Portela M.B., Souza I.P., Costa E.M., Hagler A.N., Soares R.M., and Santos A.L. Differential recovery of Candida species from subgingival sites in human immunodeficiency virus-positive and healthy children from Rio de Janeiro. Brazil J Clin Microbiol 42 12 (2004) 5925-5927
64. Chavasco J.K., Paula C.R., Hirata M.H., Aleva N.A., Melo C.E., Gambale W., et al. Molecular identification of Candida dubliniensis isolated from oral lesions of HIV-positive and HIV-negative patients in Sao Paulo, Brazil. Rev Inst Med Trop Sao Paulo 48 1 (2006) 21-26
65. Silva V., Cabrera M., Diaz M.C., Abarca C., and Hermosilla G. [Prevalence of Candida albicans serotypes in blood isolates in Chile, and first report of Candida dubliniensis candidemia]. Rev Iberoam Micol 20 2 (2003) 46-51
66. Hartung de Capriles C., Mata-Essayag S., Perez C., Colella M.T., Rosello A., Olaizola C., et al. Detection of Candida dubliniensis in Venezuela. Mycopathologia 160 3 (2005) 227-234
67. Brito Gamboa A., Mendoza M., Fernandez A., and Diaz E. Detection of Candida dubliniensis in patients with candidiasis in Caracas, Venezuela. Rev Iberoam Micol 23 2 (2006) 81-84
68. Meiller T.F., Jabra-Rizk M.A., Baqui A., Kelley J.I., Meeks V.I., Merz W.G., et al. Oral Candida dubliniensis as a clinically important species in HIV-seropositive patients in the United States. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88 5 (1999) 573-580
69. Jabra-Rizk M.A., Baqui A.A., Kelley J.I., Falkler Jr. W.A., Merz W.G., and Meiller T.F. Identification of Candida dubliniensis in a prospective study of patients in the United States. J Clin Microbiol 37 2 (1999) 321-326
70. Brown D.M., Jabra-Rizk M.A., Falkler Jr. W.A., Baqui A.A., and Meiller T.F. Identification of Candida dubliniensis in a study of HIV-seropositive pediatric dental patients. Pediatr Dent 22 3 (2000) 234-238
71. Jabra-Rizk M.A., Ferreira S.M., Sabet M., Falkler W.A., Merz W.G., and Meiller T.F. Recovery of Candida dubliniensis and other yeasts from human immunodeficiency virus-associated periodontal lesions. J Clin Microbiol 39 12 (2001) 4520-4522
72. Lefler E., McCullough M.J., Clemons K.V., and Stevens D.A. Initial isolation of Candida dubliniensis from the Middle East. Int J Infect Dis 5 1 (2001) 40-42
73. McCullough M.J., Jorge J.J., Lejbkowicz F., Lefler E., Nassar F., Clemons K.V., et al. Genotypic differences of Candida albicans and C. dubliniensis isolates related to ethnic/racial differences within the same geographic area. Mycopathologia 158 1 (2004) 39-41
74. Gugnani H.C., Becker K., Fegeler W., Basu S., Chattopadhya D., Baveja U., et al. Oropharyngeal carriage of Candida species in HIV-infected patients in India. Mycoses 46 8 (2003) 299-306
75. Tamura M., Watanabe K., Mikami Y., Yazawa K., and Nishimura K. Molecular characterization of new clinical isolates of Candida albicans and C. dubliniensis in Japan: analysis reveals a new genotype of C. albicans with group I intron. J Clin Microbiol 39 12 (2001) 4309-4315
76. Yang C.W., Barkham T.M., Chan F.Y., and Wang Y. Prevalence of Candida species, including Candida dubliniensis, in Singapore. J Clin Microbiol 41 1 (2003) 472-474
77. Tay S.T., Chai H.C., Na S.L., and Ng K.P. Molecular subtyping of clinical isolates of Candida albicans and identification of Candida dubliniensis Malaysia. Mycopathologia 159 3 (2005) 325-329
78. Sullivan D.J., Moran G.P., Pinjon E., Al-Mosaid A., Stokes C., Vaughan C., et al. Comparison of the epidemiology, drug resistance mechanisms, and virulence of Candida dubliniensis and Candida albicans. FEMS Yeast Res 4 4-5 (2004) 369-376